Background: To examine the effectiveness of osteopathic manipulative treatment
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trials.com/mrct/). Our search was supplemented by citation tracking of the identified trials and a manual search in the reference lists for all relevant papers that were not listed in the electronic databases. This search strategy was the same as a previous review (Franke et al 2014) but used the additional terms: "Pregnancy" [Mesh] and "Postpartum Period" [Mesh] . Table 1 shows an example of the applied search strategy in MEDLINE.
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Study selection
Three authors independently screened titles and abstracts of the results identified by our search strategy. Potentially eligible studies were read in full text and independently evaluated for inclusion in the current review.
Data extraction and quality assessment
Two authors independently extracted data from identified studies using a standardized data extraction form.
Dealing with missing data
If the article did not contain sufficient information, the authors were contacted for additional information. When standard deviations (SDs) were not reported, we estimated these from the confidence intervals (CIs) or other measures of variance, where possible.
Assessment of heterogeneity
Heterogeneity refers to the variation in study outcomes between studies and is useful for the interpretation of meta-analysis results. Assessment of heterogeneity was based on the calculation of I². The Cochrane Collaboration (Higgins & Green 2011) provides the following interpretation of I²: 0% to 30%, might not be important; 30% to 60%, may represent moderate heterogeneity; 50% to 90%, may represent substantial heterogeneity; and 75% to 100%, considerable heterogeneity.
Unit of analysis issues
In cases where 3 or more interventions were evaluated in a single study, we included each pair-wise comparison separately. In these instances, the total number of participants in the OMT intervention group was divided approximately evenly among the comparison groups.
Assessment of risk of bias in included studies
The methodological quality of the studies was assessed using the Risk of Bias tool of the Cochrane Back Review Group (Furlan et al 2009) . Discussion and consensus between the researchers were used to resolve disagreements about the methodological quality of the RCTs included in the current review. Every Risk of Bias criterion was scored as 'low risk', 'high risk', or 'unclear' and included assessment of randomization, blinding, baseline comparability between groups, patient compliance, and dropping out. In line with recommendations from the Cochrane Back Review Group, studies were rated as having 'low risk' when at least 6 criteria were met and the study had no serious flaws (e.g., large dropout rate). A dropout rate of greater than 20% for short-term follow-up and 30% for long-term follow-up was defined as a serious flaw and the comparison was excluded from quantitative analysis. When information was missing from the published studies and the authors could not be contacted or when the information was no longer available, the criteria were scored as 'unclear'.
Measures of treatment effect
Data for the meta-analysis was analysed using Review Manager (RevMan, Version 5.3., Nordic Cochrane Centre, http://ims.cochrane.org/revman). For measurement of pain, the NRS or VAS scores from the included studies were converted to a 100-point scale and the mean difference (MD) with 95% CIs was calculated in a random effects model. For functional status, the standard mean difference (SMD) was also used in a random effects model. The studies were grouped into 2 groups for meta-analyses: LBP in pregnant women and LBP in postpartum women. Further, subgroup analyses were conducted to examine OMT versus each specific intervention and to determine if there were differences in effects of the published and unpublished studies Assessment of clinical relevance Assessment of clinical relevance was made using the recommendations of the Cochrane Back Review Group. Therefore, we defined a small effect as MD less than 10% of the scale (e.g., 10 mm on a 100 mm VAS) and SMD or 'd' scores less than 0.5. A medium effect was defined as MD 10% to 20% of the scale and SMD or 'd' scores from 0.5 to 0.8. A large effect was defined as MD greater than 20% of the scale and SMD or 'd' scores greater than 0.8 (Furlan et al 2009) .
Data synthesis
The overall quality of the evidence for each outcome in the included studies was assessed using the GRADE approach (Guyatt et al 2011 , Kunz et al 2008 , as recommended by the updated Cochrane Back Review Group method guidelines (Furlan et al 2009) . The GRADE approach specifies 4 levels of quality, the highest rating being for RCT evidence. Authors of systematic reviews can downgrade this evidence to moderate, low, or even very low quality evidence, depending on the evaluation of quality of the evidence for each outcome against 5 key domains, which are (1) limitations in design (downgraded when more than 25% of the participants were from studies with a high risk of bias), (2) inconsistency of results (downgraded in the presence of significant statistical heterogeneity and inconsistent findings), (3) indirectness (i.e., generalizability of the findings, downgraded when more than 50% of the participants were outside the target group), (4) imprecision (downgraded when the total number of participants was less than 400 for each continuous outcome), and (5) other (such as publication bias) (Rubinstein et al 2011) .
For the current review, the following quality definitions were followed. For highquality evidence, further research was very unlikely to change our confidence in the estimate of effect. There were also consistent findings among at least 75% of RCTs with no limitations of the study design and no known or suspected reporting biases.
For moderate quality, further research was likely to have an important impact on confidence in the estimate of effect and may have changed the estimate; 1 of the domains was not met. For low quality, further research was very likely to have an important impact on confidence in the estimate of effect and was likely to change the estimate; 2 of the domains were not met. For very low quality, there was great uncertainty about the estimate; 3 of the domains were not met. For no evidence, no RCTs were identified that addressed the outcome. The research methods and reporting of this study adhered to the PRISMA guidelines (Liberati et al 2009) .
RESULTS
Included studies
The search strategy of the current review identified 102 studies. Eight studies met the inclusion criteria and were included in this review (Belz 2014 
Risk of bias
All of the included studies in the review were judged to have high internal validity (low risk of bias) where studies were rated as having 'low risk' when at least 6 criteria were met and the study had no serious flaws (Furlan et al 2009) (Table 3 ). For each of the 3 blinding criteria every study was deemed to be high risk, which is typical of most manual therapy studies.
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Effect of interventions
Results are presented in the forest plots (Figures 1-4 (2015) are less specific because this study was scheduled for 7 treatment visits to correspond with ongoing routine prenatal care at weeks 30, 32, 34, 36, 37, 38, and 39. The authors stated that 99 women completed the full 7 visits, but 357 women completed at least 4 of the scheduled 7 visits. In addition to a drop-out of 20% because of participants who became ineligible or declined to continue, additional attrition was related to delivery earlier than 39 weeks of gestation (Hensel et al. 2015) . This was considered to be a valid end point for the review, and the data was included in the current analysis.
OMT for low back and posterior pelvic pain during pregnancy (MD, 95% CI, ) and function (SMD, -1.67; 95% CI, -2.15 to -1.19) as well as in the single published study (Schwerla et al 2015) for pain (MD, 95% CI, ) and function (SMD, -3.02; 95% CI, -3.67 to -2.37).
Adverse events
Schwerla et al. (Schwerla et al 2015) noted that no serious adverse events were reported by patients, although some patients occasionally reported being tired after treatment. No other study reported on adverse events from treatment. In personal communications, the authors of 2 other studies (Belz 2014 , Gundermann 2013 reported that no adverse events occurred.
DISCUSSION
The current review found that OMT significantly improved both pain and function in women with low back and pelvic pain during pregnancy. It also found that OMT significantly improved both pain and function in women with postpartum low back and pelvic pain. The size of the effects was medium and were clinically relevant For pain during pregnancy, the current review included an additional 2 studies (Hensel et al 2015 , Röhrich 2014 , adding a further 3 comparisons and 435 participants to the analysis. The current review found a medium effect of treatment for pain, whereas the previous review found a large effect (Franke et al 2014) . For functional status during pregnancy, the current review found a medium effect of OMT, which was consistent with the previous review. Given the additional studies and larger participant numbers, the medium effects of the current review are more credible. Further, the quality of the evidence according to the GRADE approach has also improved from low to moderate in the current review.
The current review included 3 studies of OMT for women with postpartum pain. It updated the previous review (Franke et al 2014) with an additional study (Belz 2014), but the number of participants for this comparison was still small at 173. The current review found a large effect in pain and functional status in postpartum women, which was consistent with the previous review. However, the quality of the evidence as assessed using GRADE was low due to imprecision from low participant numbers and inconsistency due to heterogeneity in the analysis. The additional study (Belz 2014) There is a lack of high-quality evidence for effective treatment of low back and pelvic pain in women during and after pregnancy. In a systematic review, Liddle and Pennick (Liddle & Pennick 2015) reported that there was low-quality evidence that exercise may reduce pregnancy-related LBP and moderate-to low-quality evidence suggesting that any exercise improves functional disability. No specific form of exercise appeared to be more effective and both land and water exercises with usual prenatal care were compared to usual prenatal care only. Similar to the effects of OMT in the current review, medium effect sizes were reported for the effect of exercise. The quality of the evidence was low due to study design limitations and Although the subgroup analysis cannot be considered robust because of the lack of studies, heterogeneity, and imprecision, it appeared that the different comparisons produced different effects and may contribute to the statistical heterogeneity in the main analysis. For LBP postpartum, the comparison group was untreated (Belz 2014 , Recknagel & Roß 2007 , Schwerla et al 2015 . It is possible that usual care would produce different effects to no treatment and this should be considered when making recommendations about treatment. The lack of long-term follow-up by studies in this review is also cause for caution when making recommendations.
Given the moderate and low levels of evidence and the likely impact of further research, more studies on these research questions are needed, in particular, highquality studies with large sample sizes, robust comparisons, and adequate follow-up.
Only 1 study reported the presence or absence of adverse events, so future studies should make a statement on adverse events and adhere to recommended reporting guidelines (Schulz et al 2010).
CONCLUSIONS
The current review updated a previous review (Franke et al 2014) on the effectiveness of OMT for pregnancy-related LBP. We found moderate-quality evidence that OMT had a significant medium-sized effect on decreasing pain and increasing functional status in women with LBP during pregnancy and low-quality evidence that OMT had a significant large-sized effect on decreasing pain and increasing functional status for postpartum LBP. Our results suggest that OMT may produce clinically relevant benefits for women with these conditions. Given the small sample sizes, different comparison groups, statistical heterogeneity, and lack of long-term follow-up, large high-quality RCTs are still needed to provide more confident conclusions regarding the effectiveness of OMT for LBP in women during pregnancy and postpartum. 1 The outcome measurement of the 5th treatment was incorrectly reported; the measurements after 4 treatments were used for analysis. *The basis for the assumed risk (e.g., the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval.
GRADE Working Group grades of evidence 
